![Bill Would Require Medicare to Cover New Breakthrough Devices for at Least 4 Years](https://www.g2intelligence.com/wp-content/uploads/2023/05/May23.LIR_.FDAWatch-iStock-1404962439-1100x800-1-1080x675.jpg)
Bill Would Require Medicare to Cover New Breakthrough Devices for at Least 4 Years
The bill is designed to provide Medicare patients faster access to innovative technology approved by the FDA.
The bill is designed to provide Medicare patients faster access to innovative technology approved by the FDA.
On March 28, the 118th Congress raised lab industry hopes once more by reintroducing the Saving Access to Laboratory Services Act (SALSA).
It’s not just billions of dollars on the line, but the very future of whistleblower lawsuits and FCA enforcement.
The bipartisan bill was recently reintroduced to amend the FCA in response to a landmark 2016 Supreme Court ruling.
New legislation would force CMS to change the way it calculates Medicare prices for lab tests.